Search research articles
Contact Us
Filters
Showing results (901-910 of 976) with videos related to
Page
of 98
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
March 7, 2024
Clinical and prognostic differences in oropharyngeal squamous cell carcinoma in USA and Denmark, two HPV high-prevalence areas
Amanda-Louise Fenger Carlander, Simone Kloch Bendtsen, Jacob H Rasmussen, et al.
Thyroid : Official Journal of the American Thyroid Association
|
August 25, 2018
Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions
Samantha Tam, Mongkol Boonsripitayanon, Moran Amit, et al.
Health Physics
|
March 27, 2015
Use of radiopharmaceuticals in diagnostic nuclear medicine in the United States: 1960-2010
Vladimir Drozdovitch, Aaron B Brill, Ronald J Callahan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 3, 2022
Discovery of a functionally selective ghrelin receptor (GHSR<sub>1a</sub>) ligand for modulating brain dopamine
J D Gross, D W Kim, Y Zhou, et al.
Health Physics
|
August 28, 2014
Nuclear medicine practices in the 1950s through the mid-1970s and occupational radiation doses to technologists from diagnostic radioisotope procedures
Vladimir Drozdovitch, Aaron B Brill, Fred A Mettler, et al.
Plos Pathogens
|
January 6, 2018
Fab-based inhibitors reveal ubiquitin independent functions for HIV Vif neutralization of APOBEC3 restriction factors
Jennifer M Binning, Amber M Smith, Judd F Hultquist, et al.
JAMA Oncology
|
August 8, 2020
Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019
Anastasios Maniakas, Ramona Dadu, Naifa L Busaidy, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 12, 2011
Discovery and SAR of spirochromane Akt inhibitors
Nicholas C Kallan, Keith L Spencer, James F Blake, et al.
Journal of Medicinal Chemistry
|
June 25, 2004
3-(2-aminoalkyl)-1-(2,6-difluorobenzyl)-5- (2-fluoro-3-methoxyphenyl)-6-methyl-uracils as orally bioavailable antagonists of the human gonadotropin releasing hormone receptor
Fabio C Tucci, Yun-Fei Zhu, Zhiqiang Guo, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 3, 2010
Discovery of pyrrolopyrimidine inhibitors of Akt
James F Blake, Nicholas C Kallan, Dengming Xiao, et al.
Page
of 98
Search research articles
Search
Showing results (901-910 of 976) with videos related to
Sort By:
Page
of 98
European Journal of Cancer (Oxford, England : 1990)
|
March 7, 2024
Clinical and prognostic differences in oropharyngeal squamous cell carcinoma in USA and Denmark, two HPV high-prevalence areas
Amanda-Louise Fenger Carlander, Simone Kloch Bendtsen, Jacob H Rasmussen, et al.
Thyroid : Official Journal of the American Thyroid Association
|
August 25, 2018
Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions
Samantha Tam, Mongkol Boonsripitayanon, Moran Amit, et al.
Health Physics
|
March 27, 2015
Use of radiopharmaceuticals in diagnostic nuclear medicine in the United States: 1960-2010
Vladimir Drozdovitch, Aaron B Brill, Ronald J Callahan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 3, 2022
Discovery of a functionally selective ghrelin receptor (GHSR<sub>1a</sub>) ligand for modulating brain dopamine
J D Gross, D W Kim, Y Zhou, et al.
Health Physics
|
August 28, 2014
Nuclear medicine practices in the 1950s through the mid-1970s and occupational radiation doses to technologists from diagnostic radioisotope procedures
Vladimir Drozdovitch, Aaron B Brill, Fred A Mettler, et al.
Plos Pathogens
|
January 6, 2018
Fab-based inhibitors reveal ubiquitin independent functions for HIV Vif neutralization of APOBEC3 restriction factors
Jennifer M Binning, Amber M Smith, Judd F Hultquist, et al.
JAMA Oncology
|
August 8, 2020
Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019
Anastasios Maniakas, Ramona Dadu, Naifa L Busaidy, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 12, 2011
Discovery and SAR of spirochromane Akt inhibitors
Nicholas C Kallan, Keith L Spencer, James F Blake, et al.
Journal of Medicinal Chemistry
|
June 25, 2004
3-(2-aminoalkyl)-1-(2,6-difluorobenzyl)-5- (2-fluoro-3-methoxyphenyl)-6-methyl-uracils as orally bioavailable antagonists of the human gonadotropin releasing hormone receptor
Fabio C Tucci, Yun-Fei Zhu, Zhiqiang Guo, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 3, 2010
Discovery of pyrrolopyrimidine inhibitors of Akt
James F Blake, Nicholas C Kallan, Dengming Xiao, et al.
Page
of 98